13.08USD-0.21%Mkt Cap: 10.46B $P/E: —Today
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate …
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap10.46B $
Enterprise Value9.25B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.08B $
Revenue/Share—
Last Price13.08 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees265
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.33
PEG—
EV/EBITDA-10.57
EV/Revenue—
P/S—
P/B15.65
EPS (TTM)-1.05
EPS (Forward)-1.20
52W Range
12.076% of range30.05
52W High30.05 USD
52W Low12.07 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-163.86%
ROA-143.72%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-322.93M $
CapEx (TTM)657.00K $
FCF Margin—
FCF Yield-1.34%
Net Debt-670.29M $
Net Debt/EBITDA0.77
Balance Sheet
Debt/Equity0.03
Current Ratio6.96
Quick Ratio6.67
Book Value/Sh0.7940 USD
Cash/Share0.8660 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.64 USD
Upside (mean)+118.9%
Target Range9.907 USD – 42.03 USD
$9.907+118.9% to mean$42.03
# Analysts13
Ownership
Shares Out.797.75M
Float152.28M
Insiders80.89%
Institutions17.36%
Short Interest
Short Ratio9.3d
Short % Float23.17%
Short % Out.4.54%
Shares Short36.25M
Short (prev mo.)39.86M
Technical
SMA 5014.10 (-7.2%)
SMA 20016.62 (-21.3%)
Beta-1.24
S&P 52W Chg18.16%
Avg Vol (30d)4.12M
Avg Vol (10d)5.71M
Technical Indicators
RSI (14)42.8
MACD-0.2379
MACD Signal-0.2094
MACD Hist.-0.0285
BB Upper15.38 USD
BB Middle13.72 USD
BB Lower12.07 USD
BB Width24.13%
ATR (14)0.8721 USD
Vol Ratio (20d)1.17x